Company Filing History:
1 out of 560 
1 out of 270 
Years Active: 2016-2023
Title: Innovations and Contributions of Poulikos Poulikakos
Introduction
Poulikos Poulikakos is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer research, particularly in the development of novel therapeutic strategies. With a total of 2 patents, his work focuses on addressing critical challenges in cancer treatment.
Latest Patents
Poulikos Poulikakos holds two notable patents. The first patent is titled "Compositions and methods for treating CDK4/6-mediated cancer." This invention provides methods for designing heterobifunctional small molecules that selectively degrade or disrupt CDK4/6. It also includes compositions and methods for using these degraders or disruptors to treat CDK4/6-mediated cancer. The second patent is "Methods and compositions for the detection of drug-resistant BRAF isoforms." This invention offers methods and compositions for detecting novel BRAF splice variants that mediate resistance to BRAF and/or pan-RAF inhibitors. It includes PCR primers for detection and provides alternative treatment strategies for subjects predicted to be resistant to these inhibitors.
Career Highlights
Throughout his career, Poulikos has worked with esteemed institutions such as Memorial Sloan Kettering Cancer Center and the Icahn School of Medicine at Mount Sinai. His research has significantly advanced the understanding of cancer biology and therapeutic resistance.
Collaborations
He has collaborated with notable colleagues, including Neal Rosen and David Solit, contributing to a rich exchange of ideas and innovations in cancer research.
Conclusion
Poulikos Poulikakos is a distinguished inventor whose work has the potential to transform cancer treatment. His patents reflect a commitment to addressing critical issues in oncology, making him a valuable contributor to the field.